Redsense Medical AB (publ)
RDSNF
$0.51
-$0.54-51.43%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 53.87% | -61.09% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 53.87% | -61.09% | |||
| Cost of Revenue | 14.56% | -44.09% | |||
| Gross Profit | 97.11% | -70.84% | |||
| SG&A Expenses | 54.01% | -16.40% | |||
| Depreciation & Amortization | 6.67% | -6.25% | |||
| Other Operating Expenses | -39.01% | 215.45% | |||
| Total Operating Expenses | 18.66% | 13.48% | |||
| Operating Income | 35.85% | -157.74% | |||
| Income Before Tax | 35.91% | -156.63% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 35.91% | -156.63% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 35.91% | -156.63% | |||
| EBIT | 35.85% | -157.74% | |||
| EBITDA | 36.03% | -157.27% | |||
| EPS Basic | 35.39% | -156.51% | |||
| Normalized Basic EPS | 35.14% | -156.35% | |||
| EPS Diluted | 35.39% | -156.51% | |||
| Normalized Diluted EPS | 35.14% | -156.35% | |||
| Average Basic Shares Outstanding | -0.87% | 0.20% | |||
| Average Diluted Shares Outstanding | -0.87% | 0.20% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||